This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: Brexit

Cardiovascular research 2018 handbook: <br>Brexit – threat or opportunity

September 2018 doi:10.5837/bjc.2018.s11

Cardiovascular research 2018 handbook:
Brexit – threat or opportunity

BJC Staff

Abstract

Importance of UK collaboration with the EU The partnerships between the UK and other EU Member States significantly increase the impact and influence of the EU’s science and research activity. When collaborating with the UK, the share of EU co-authored publications in the top 10% of highly cited publications in medical and health research is higher.2 The UK is also a top five collaboration partner for each of the other 27 Member States,3 and contributed almost 20% of the total research work carried out within EU health programmes between 2007–2016.2 European collaboration is particularly important in some fields – stratified medicine a

| Full text
Implications of Brexit for medical research

April 2018 Br J Cardiol 2018;25:48–9 doi:10.5837/bjc.2018.009 Online First

Implications of Brexit for medical research

Chloe Watson

Abstract

When it comes to cardiovascular disease (CVD), UK research has had (and continues to have) an enormous impact across the world – from influencing global care guidelines on hypertension to ensuring the right people are using statins to prevent a heart attack or stroke. These advances are helping people to live longer, healthier lives. Since the British Heart Foundation (BHF) was founded in 1961, UK death rates from CVD have fallen by more than half, and seven out of 10 people now survive a heart attack. Secrets of success So what have been the ingredients for this success, and how can we retain and build on these to ensure that the future

| Full text
In brief

November 2016 Br J Cardiol 2016;23:137

In brief

BJCardio Staff

Abstract

Physio-Control, a global leader in lifesaving emergency response technology, is launching a new automated external defibrillator (AED) in European countries (LIFEPAK® CR2). The LIFEPAK® AED Response System: Features a new design intended for ease of use by bystanders and rescuers Launches new technology that supports high quality cardiopulmonary resuscitation Has been demonstrated to offer faster time-to-first-shock Deploys a new remote monitoring and connectivity capability through the online LIFELINKcentral™ AED Program Manager. The CR2 can be remotely monitored and can even, in some areas, transmit a heart rhythm to emergency medical

| Full text
Cut out the middleman

November 2016 Br J Cardiol 2016;23:127 doi:10.5837/bjc.2016.035

Cut out the middleman

Terry McCormack

Abstract

Terry McCormack (Spring Vale Medical Centre, North Yorkshire) It was, therefore, with great interest that I read the paper by Coughlan et al. (see pages 138–40). The authors raise very important points regarding both the importance of adequate discharge information and the poor delivery of appropriate up-titration of medicines when the patient has arrived home post-ST-elevation myocardial infarction (STEMI). They cite the failure of junior doctors to give adequate instructions to GPs on how to up-titrate medications and how educating the juniors improved performance. But they raise more questions than they answer. Why not have a pre-printed

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now